Article info
PDFRheumatoid arthritis
Recommendation
Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry
- Correspondence to Dr Sofie HM Manders; sofie.manders{at}radboudumc.nl
Citation
Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry
Publication history
- Received June 30, 2015
- Revision received August 24, 2015
- Accepted August 31, 2015
- First published October 8, 2015.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/